Arkolith/Insider Trading/SAGE/Form 4

Benecchi Christopher

Chief Operating OfficerSage Therapeutics, Inc. (SAGE) · full profile →Form 4 · filed Apr 11, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 10, 2025Tax withholding(F)793$6.91$5K46K
Apr 10, 2025Tax withholding(F)661$6.91$5K48K
Apr 10, 2025Grant(A)3K—$049K
Apr 10, 2025Grant(A)3K—$047K

Transaction Codes

F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-25-003114) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML